0001209191-17-001579.txt : 20170104 0001209191-17-001579.hdr.sgml : 20170104 20170104200741 ACCESSION NUMBER: 0001209191-17-001579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170101 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cappel Markus J. CENTRAL INDEX KEY: 0001422995 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 17508229 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-01 0 0001340652 ChemoCentryx, Inc. CCXI 0001422995 Cappel Markus J. C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 Chief Bus. Officer & Treasurer Common Stock 2017-01-01 4 M 0 8333 0.00 A 20833 D Common Stock 2017-01-01 4 F 0 4442 7.40 D 16391 D Common Stock 2017-01-03 4 M 0 26821 4.30 A 43212 D Common Stock 2017-01-03 4 S 0 26821 7.5055 D 16391 D Restricted Stock Units 2017-01-01 4 M 0 8333 D Common Stock 8333 16667 D Stock Option (right to buy) 4.30 2017-01-03 4 M 0 26821 D 2007-02-06 2017-02-06 Common Stock 26821 0 D Shares were acquired upon vesting of restricted stock units awarded on March 7, 2016. Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation. The sales reported in this Form 4 were effected pursuant to a June 2016 Rule 10b5-1 trading plan adopted by the Reporting Person. Shares sold are associated with stock options which will expire in February 2017. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.50 to $7.59 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. The restricted stock units vest in three equal installments on January 1, 2017, January 1, 2018, and January 1, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. As of January 3, 2017, and prior to this transaction, the option fully vested. Not applicable. /s/ Susan M. Kanaya, as Attorney-in-Fact 2017-01-04